161 related articles for article (PubMed ID: 34410446)
1. Hydroxycitrate prevents calcium oxalate crystallization and kidney injury in a nephrolithiasis rat model.
Yang B; Li J; Wang B; Wang G; Li P; Guo H; Li Y; Yang T
Urolithiasis; 2022 Feb; 50(1):47-53. PubMed ID: 34410446
[TBL] [Abstract][Full Text] [Related]
2. Hydroxycitric Acid Inhibits Renal Calcium Oxalate Deposition by Reducing Oxidative Stress and Inflammation.
Liu X; Yuan P; Sun X; Chen Z
Curr Mol Med; 2020; 20(7):527-535. PubMed ID: 31902360
[TBL] [Abstract][Full Text] [Related]
3. Glycine suppresses kidney calcium oxalate crystal depositions via regulating urinary excretions of oxalate and citrate.
Lan Y; Zhu W; Duan X; Deng T; Li S; Liu Y; Yang Z; Wen Y; Luo L; Zhao S; Wang J; Zhao Z; Wu W; Zeng G
J Cell Physiol; 2021 Oct; 236(10):6824-6835. PubMed ID: 33772775
[TBL] [Abstract][Full Text] [Related]
4. Autophagy-endoplasmic reticulum stress inhibition mechanism of superoxide dismutase in the formation of calcium oxalate kidney stones.
Kang J; Sun Y; Deng Y; Liu Q; Li D; Liu Y; Guan X; Tao Z; Wang X
Biomed Pharmacother; 2020 Jan; 121():109649. PubMed ID: 31733571
[TBL] [Abstract][Full Text] [Related]
5. Clinical-grade Garcinia cambogia extract dissolves calcium oxalate crystals in Drosophila kidney stone models.
Fan QX; Gong SQ; Hong XZ; Feng XM; Zhang FJ
Eur Rev Med Pharmacol Sci; 2020 Jun; 24(11):6434-6445. PubMed ID: 32572941
[TBL] [Abstract][Full Text] [Related]
6. Hydroxycitric Acid Tripotassium Inhibits Calcium Oxalate Crystal Formation in the Drosophila Melanogaster Model of Hyperoxaluria.
Han S; Zhao C; Pokhrel G; Sun X; Chen Z; Xu H
Med Sci Monit; 2019 May; 25():3662-3667. PubMed ID: 31099342
[TBL] [Abstract][Full Text] [Related]
7. Vitamin E therapy prevents hyperoxaluria-induced calcium oxalate crystal deposition in the kidney by improving renal tissue antioxidant status.
Thamilselvan S; Menon M
BJU Int; 2005 Jul; 96(1):117-26. PubMed ID: 15963133
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of Autophagy Attenuated Ethylene Glycol Induced Crystals Deposition and Renal Injury in a Rat Model of Nephrolithiasis.
Liu Y; Liu Q; Wang X; He Z; Li D; Guan X; Tao Z; Deng Y
Kidney Blood Press Res; 2018; 43(1):246-255. PubMed ID: 29490299
[TBL] [Abstract][Full Text] [Related]
9. Increased abundance of bacteria of the family Muribaculaceae achieved by fecal microbiome transplantation correlates with the inhibition of kidney calcium oxalate stone deposition in experimental rats.
Wang Y; Sun J; Xie S; Zhou Y; Wang T; Liu Z; Li C; Gao L; Pan T
Front Cell Infect Microbiol; 2023; 13():1145196. PubMed ID: 37313343
[TBL] [Abstract][Full Text] [Related]
10. Experimental calcium oxalate nephrolithiasis and the formation of human urinary stones.
Khan SR
Scanning Microsc; 1995 Mar; 9(1):89-100; discussion 100-1. PubMed ID: 8553028
[TBL] [Abstract][Full Text] [Related]
11. Catechin prevents the calcium oxalate monohydrate induced renal calcium crystallization in NRK-52E cells and the ethylene glycol induced renal stone formation in rat.
Zhai W; Zheng J; Yao X; Peng B; Liu M; Huang J; Wang G; Xu Y
BMC Complement Altern Med; 2013 Sep; 13():228. PubMed ID: 24044655
[TBL] [Abstract][Full Text] [Related]
12. Total flavonoids of Desmodium styracifolium attenuates the formation of hydroxy-L-proline-induced calcium oxalate urolithiasis in rats.
Zhou J; Jin J; Li X; Zhao Z; Zhang L; Wang Q; Li J; Zhang Q; Xiang S
Urolithiasis; 2018 Jun; 46(3):231-241. PubMed ID: 28567512
[TBL] [Abstract][Full Text] [Related]
13. Study of a rat model for calcium oxalate crystal formation without severe renal damage in selected conditions.
Yamaguchi S; Wiessner JH; Hasegawa AT; Hung LY; Mandel GS; Mandel NS
Int J Urol; 2005 Mar; 12(3):290-8. PubMed ID: 15828958
[TBL] [Abstract][Full Text] [Related]
14. The relationship between gut microbiota and short chain fatty acids in the renal calcium oxalate stones disease.
Liu Y; Jin X; Hong HG; Xiang L; Jiang Q; Ma Y; Chen Z; Cheng L; Jian Z; Wei Z; Ai J; Qi S; Sun Q; Li H; Li Y; Wang K
FASEB J; 2020 Aug; 34(8):11200-11214. PubMed ID: 32645241
[TBL] [Abstract][Full Text] [Related]
15. Animal models of kidney stone formation: an analysis.
Khan SR
World J Urol; 1997; 15(4):236-43. PubMed ID: 9280052
[TBL] [Abstract][Full Text] [Related]
16. Oxygen nano-bubble water reduces calcium oxalate deposits and tubular cell injury in ethylene glycol-treated rat kidney.
Hirose Y; Yasui T; Taguchi K; Fujii Y; Niimi K; Hamamoto S; Okada A; Kubota Y; Kawai N; Itoh Y; Tozawa K; Sasaki S; Kohri K
Urolithiasis; 2013 Aug; 41(4):279-94. PubMed ID: 23754513
[TBL] [Abstract][Full Text] [Related]
17. Molecular modifiers reveal a mechanism of pathological crystal growth inhibition.
Chung J; Granja I; Taylor MG; Mpourmpakis G; Asplin JR; Rimer JD
Nature; 2016 Aug; 536(7617):446-50. PubMed ID: 27501150
[TBL] [Abstract][Full Text] [Related]
18. Targeting urinary calcium oxalate crystallization with inulin-type AOFOS from Aspidopterys obcordata Hemsl. for the management of rat urolithiasis.
Sun P; Yue J; Lu C; Ji K; Yang R; Lu J; Song X; Hu H; Zhao J; Yang Y; Xu Y
J Ethnopharmacol; 2024 Jul; 329():118149. PubMed ID: 38580188
[TBL] [Abstract][Full Text] [Related]
19. Hydroxycitrate: a potential new therapy for calcium urolithiasis.
Kim D; Rimer JD; Asplin JR
Urolithiasis; 2019 Aug; 47(4):311-320. PubMed ID: 30915494
[TBL] [Abstract][Full Text] [Related]
20. Successful formation of calcium oxalate crystal deposition in mouse kidney by intraabdominal glyoxylate injection.
Okada A; Nomura S; Higashibata Y; Hirose M; Gao B; Yoshimura M; Itoh Y; Yasui T; Tozawa K; Kohri K
Urol Res; 2007 Apr; 35(2):89-99. PubMed ID: 17393196
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
